全国性研究:活动性心内膜炎二尖瓣修复与置换的比较
基于荷兰全国前瞻性数据库,纳入2013至2020年因活动性感染性心内膜炎行首次二尖瓣手术的成人患者715例,其中294例(41.1%)接受瓣膜修复。风险校正分析显示,与瓣膜修复相比,二尖瓣置换的结果较差(校正风险比2.216;95%CI 1.425-3.448;P<.001),地标分析及倾向评分校正分析结果一致。
要点
- 活动性心内膜炎二尖瓣手术中,瓣膜修复率为41.1%(294/715),研究期间呈轻微下降趋势。
- 早期死亡率为13.0%,研究期间呈稳步下降趋势,但患者复杂性持续增加。
- 风险校正后,二尖瓣置换较瓣膜修复结果较差(校正HR 2.216;95%CI 1.425-3.448;P<.001)。
核心结论
- 当代活动性感染性心内膜炎二尖瓣手术趋势提示患者复杂性增加但早期死亡率轻微下降,瓣膜修复率呈下降趋势。
- 本研究结果提示,与瓣膜置换相比,瓣膜修复的晚期结局更好。
研究设计与样本
- 基于荷兰全国前瞻性数据库(涵盖全国所有心脏外科手术)的全国性研究。
- 纳入2013至2020年因活动性感染性心内膜炎行首次二尖瓣干预的成人患者715例,其中294例(41.1%)接受瓣膜修复。
- 生存分析覆盖整个随访期,并应用90天地标分析。
主要发现
- 715例患者中294例(41.1%)接受瓣膜修复,研究期间二尖瓣修复率轻微下降。
- 早期死亡率为13.0%,研究期间早期死亡率呈稳步下降趋势,同时患者复杂性持续增加。
- 风险校正分析中,二尖瓣置换较瓣膜修复结果较差(校正风险比2.216;95%CI 1.425-3.448;P<.001)。
- 地标分析后,二尖瓣置换较瓣膜修复结果仍较差(校正风险比2.489;95%CI 1.124-5.516;P=.025)。
- 倾向评分校正分析证实上述结果(校正风险比2.251;95%CI 1.029-4.21;P=.042)。
临床怎么用
- 原文未据此给出推荐,仅指出本研究结果提示瓣膜修复较瓣膜置换的晚期结局更好。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Real-world evidence supporting the reproducibility and superiority of valve repair over replacement in active mitral valve infective endocarditis is lacking. METHODS: Data from a prospective nationwide database, including all cardiac surgical procedures in The Netherlands, were used. Adult patients undergoing primary mitral valve intervention who had a diagnosis of active infective endocarditis and who underwent surgery between 2013 and 2020 were included. Survival analysis was performed for the whole follow-up period as well as after applying the landmark of 90 days. RESULTS: Of 715 patients who met the inclusion criteria, 294 (41.1%) underwent valve repair. Mitral valve repair rates decreased slightly over the course of the study. The early mortality rate was 13.0%, and a trend of steadily declining early mortality rates over the course of the study, despite a steady increase in patient complexity, was observed. On risk-adjusted analysis, mitral valve replacement demonstrated inferior results when compared with valve repair (adjusted hazard ratio, 2.216; 95% CI, 1.425-3.448; P < .001), even after a landmark analysis was performed (adjusted hazard ratio 2.489; 95% CI, 1.124-5.516; P = .025). These results were confirmed by a propensity score-adjusted analysis (adjusted hazard ratio 2.251; 95% CI, 1.029-4.21; P = .042). CONCLUSIONS: Contemporary trends in mitral valve surgery for active infective endocarditis suggest growing patient complexity but slightly declining early mortality rates. A trend of decreasing mitral valve repair rates was seen. The results of this study suggest improved late outcomes of valve repair compared with valve replacement.
引用
- Tomšič A, de Weger A, van der Stoel M, et al. A Nationwide Study on Mitral Valve Repair vs Replacement for Active Endocarditis. Ann Thorac Surg. 2023. PMID: 37714504. doi:10.1016/j.athoracsur.2023.08.032
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。